GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Adolor Corporation (ADLR) [hlAlert]

Rating:
Buy ADLR
up 7.91 %

Adolor Corporation (ADLR) rated Buy

Posted on: Wednesday,  Dec 5, 2007  11:25 AM ET by Pacific Growth Equities

Pacific Growth Equities rated Buy Adolor Corporation (NASDAQ: ADLR) on 12/05/2007, when the stock price was $4.42. Since
then, Adolor Corporation has gained 7.92% as of 12/09/2011's recent price of $4.77.
If you would have followed this Pacific Growth Equities's recommendation on ADLR, you would have gained 7.91% of your investment in 1465 days.

Adolor Corporation is a biopharmaceutical company. The Company has specialized in the discovery and development of prescription pain management products. It has a number of product candidates in various stages of development, ranging from preclinical studies to pivotal clinical trials. On May 20, 2008, the United States Food and Drug Administration (FDA) approved the Company?s first product, ENTEREG (alvimopan), for the management of postoperative ileus following bowel resection surgery (POI). ENTEREG is specifically indicated to accelerate the time to upper and lower gastrointestinal recovery following partial large or small bowel resection surgery with primary anastomosis. The Company in collaboration with Glaxo Group Limited (Glaxo), launched ENTEREG in the United States in mid-2008.

The Pacific Growth Equities research department strives to stay ahead of breaking news in some of the fastest moving and most complicated industries on Wall Street. Our research names are affected not only by economic swings but also by specific government regulations, new legislation, and often public opinion. Staying on top of every nuance allows us—and our clients—to lead and not follow. We take pride in providing incremental, value-added insights to the global institutional investment community. Our analysts are experienced in both industry and Wall Street, and are empowered to make the tough calls. Research insights are delivered quickly to the appropriate decision-makers so that important investment opportunities will not be lost. Any research analyst can call an impromptu meeting when news is breaking, to keep the sales force and management abreast of events that could impact the market both from a macro point of view and from one that is stock-specific.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
12/5/2007 11:25 AM Buy
None
4.42
as of 8/27/2015
1 Week   
1 Month   
3 Months   
1 YTD up  45.87 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy